Vol.54 No.2 March 2006

Drug resistance caused by qualitative changes in respiratory pathogen components

Kimiko Ubukata

Jpn. J. Chemother. 54 (2): 69-94, 2006

In vitro combination effect of glycopeptides and β-lactams against methicillin-resistant Staphylococcus aureus

Yoshitake Sato, Mitsuru Sando, Satoshi Iwata, Hironobu Akita and Keisuke Sunakawa

Jpn. J. Chemother. 54 (2): 95-101, 2006

Antibacterial effect of linezolid against methicillin-resistant Staphylococcus aureus evaluated using colorimetry and chemiluminescence-based drug-susceptibility tests

Mitsutaka Komatsu, Yutaka Tajima, Teruyo Ito, Yuichiro Yamashiro and Keiichi Hiramatsu

Jpn. J. Chemother. 54 (2): 102-110, 2006

Analyses of treatment days and cost of panipenem/betamipron and cefozopran therapy in the treatment of respiratory tract infections

Keisuke Sunakawa, Makoto Kobayashi, Hajime Goto and Koichi Wada

Jpn. J. Chemother. 54 (2): 111-124, 2006

The efficacy of Micafungin as an empiric therapy for febrile neutropenic patients refractory to antibacterial agents

Takahiko Ishikawa, Tohru Takata, Takeaki Tomoyose, Masato Masuda, Sawako Nakachi, Shin Koga, Junichi Tsukada, Ai Matsuura, Atae Utsunomiya, Yoshio Saburi and Kazuo Tamura

Jpn. J. Chemother. 54 (2): 125-128, 2006